Skip to main content
Equibles

Tower Research Capital LLC (TRC)

Position in INKT — MiNK Therapeutics, Inc.

CIK 1533421 NEW YORK, NY
Back to INKT Full portfolio

Position in INKT

as of Jun 30, 2026 · filed Aug 11, 2026
Position Value
$4,933
+$3,291 QoQ
Shares Held
422
+170.5% QoQ
Ownership
0.008%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#13
of 27 holders
Holding Since
Dec 2021
15 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in INKT Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Tower Research Capital LLC (TRC) holds $49,739,988 across 466 Biotechnology names. INKT ranks #362 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ARGX
Argenx SE
 4,547 $4,218,570
2 BBIO
BridgeBio Pharma, Inc.
 38,206 $2,845,582
3 ARWR
Arrowhead Pharmaceuticals, Inc.
 34,537 $2,815,110
4 VRTX
Vertex Pharmaceuticals Inc / Ma
 4,292 $2,131,964
5 MDGL
Madrigal Pharmaceuticals, Inc.
 3,927 $2,108,602
6 AXSM
Axsome Therapeutics, Inc.
 6,437 $1,575,584
7 INSM
INSMED Inc
 10,927 $1,165,036
8 ROIV
Roivant Sciences Ltd.
 32,746 $1,158,880

All Filings in INKT

Export CSV
15 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $4,933 422
2026-03-31 $1,642 156
2025-12-31 $3,289 295
2025-09-30 $12,964 926
2025-03-31 $1,486 172
2024-12-31 $3,764 5,401
2024-09-30 $3,020 4,027
2024-06-30 $8,490 8,947
2024-03-31 $10,042 11,060
2023-12-31 $11,709 10,943
2023-09-30 $8,464 7,695
2023-06-30 $23,412 11,149
2022-06-30 $1,556 1,104
2022-03-31 $5,105 2,269
2021-12-31 $8,143 1,826